Updates on GMSCs Treatment for Autoimmune Diseases
Feng Huang1, Zhong Ming Liu2, Song Guo Zheng3
1Department of Clinical Immunology, Third Hospital at Sun Yat-sen Universirty, Guangzhou, 510630, China.
Current Stem Cell Research & Therapy
|February 23, 2018
Summary
Human gingiva-derived mesenchymal stem cells (GMSCs) show promise for treating autoimmune diseases due to their differentiation and anti-inflammatory properties. Further clinical trials are needed to confirm their therapeutic potential and mechanisms.
Area of Science:
- Immunology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Autoimmune diseases are challenging to treat.
- Mesenchymal stem cells (MSCs) show potential for managing autoimmune conditions.
- Human gingiva-derived mesenchymal stem cells (GMSCs) offer unique advantages for autoimmune disease treatment.
Purpose of the Study:
- To review the biology of GMSCs.
- To summarize the effects of GMSCs on autoimmune diseases.
- To highlight GMSCs as a potential therapeutic strategy.
Main Methods:
- Literature review of GMSC biology and therapeutic applications.
- Analysis of studies on GMSC differentiation and immunomodulation.
- Evaluation of current research on GMSCs in autoimmune disease models.
Main Results:
- GMSCs possess multi-directional differentiation capacity.
- GMSCs exhibit potent inflammatory modulation properties.
- GMSCs demonstrate potential in preclinical models of autoimmune diseases.
Conclusions:
- GMSCs are a promising subtype of MSCs for autoimmune disease therapy.
- GMSC's differentiation and anti-inflammatory capabilities are key therapeutic assets.
- Clinical trials are essential to validate GMSC efficacy and elucidate mechanisms.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:22Alzheimer's Disease: Treatment
981
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
981
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
524
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
524
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
559
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
559
01:29Autoimmune Disorders
1.9K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.9K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
588
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
588